OTC Markets OTCQB USD
NUREXONE BIOLOGIC INC (NRXBF)
0.4826
-0.0069
(-1.41%)
At close: June 12 at 8:00:00 PM EDT
Breakdown
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Assets
2,441
2,170
2,794
2,836
Total Liabilities Net Minority Interest
680
1,981
698
1,659
Total Equity Gross Minority Interest
1,761
189
2,096
1,177
Total Capitalization
1,761
189
2,096
1,177
Common Stock Equity
1,761
189
2,096
1,177
Capital Lease Obligations
33
20
44
0
Net Tangible Assets
1,761
189
2,096
1,177
Working Capital
1,236
74
2,089
1,205
Invested Capital
1,761
189
2,096
2,220
Tangible Book Value
1,761
189
2,096
1,177
Total Debt
33
20
44
1,043
Share Issued
71,073.5980
48,249.7070
42,855.1580
42,855.1580
Ordinary Shares Number
71,073.5980
48,249.7070
42,855.1580
42,855.1580
Treasury Shares Number
--
0
--
--
12/31/2021 - 11/10/2023
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
BT3.BE Lineage Cell Therapeutics Inc
0.5850
-0.85%
AB3A.MU Sarepta Therapeutics Inc
31.82
-1.18%
GXE.F Galapagos NV
24.76
+0.08%
ITRX inTerra Resources Corp
0.0240
0.00%
8QQ.BE AbCellera Biologics Inc
2.5800
-6.99%
GENSY Genus plc
24.34
0.00%
AYJ.HA Valneva SE
2.6180
-4.10%
ONCIN.OL Oncoinvent ASA
1.8500
-8.64%
300759.SZ Pharmaron Beijing Co., Ltd.
24.84
-2.47%
T3X.BE Telix Pharmaceuticals Ltd
13.93
-5.63%